Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Itron, Inc. (NASDAQ: ITRI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Itron is incorporated in Washington and reports under Commission File Number 000-22418. Through these filings, investors can review details about Itron’s intelligent infrastructure business for energy, water and city services, along with its financial condition and material corporate events.
Key documents for ITRI include current reports on Form 8-K, which disclose material events such as agreements to acquire software and services companies serving utilities, approval of share repurchase programs, entry into credit agreements and the release of quarterly financial results. These filings also cover board appointments and other governance matters. Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) provide broader context on Itron’s Device Solutions, Networked Solutions and Outcomes segments, as well as risk factors and segment information.
On Stock Titan, Itron filings are updated in near real time as they appear in the SEC’s EDGAR system. AI-powered summaries help explain the significance of lengthy documents, highlighting items such as new credit facilities, acquisition agreements, share repurchase authorizations and results of operations. Users can quickly see which filings relate to capital structure, financing arrangements or strategic transactions.
For those tracking insider and governance activity, this page also serves as a gateway to Form 4 insider transaction reports and proxy-related disclosures when they are filed. Together, these documents give a structured view of how Itron manages its capital, executes acquisitions and reports on its intelligent infrastructure business to regulators and shareholders.
ITRI reported a Form 144 disclosing that Thomas L. Deitrich sold 1,750 common shares on
The filing lists an additional holding line showing 56,095 common shares with a value of
Itron, Inc. filed its annual report describing how it helps utilities and cities manage energy, water, and critical infrastructure through devices, networked solutions, software, and services. The company now reports four segments, adding a new Resiliency Solutions segment in late 2025 and broadening its software offerings with the acquisition of Urbint, Inc.
Itron reported $2.1 billion in total bookings and $4.5 billion in total backlog at December 31, 2025, with $1.6 billion expected over 12 months. Research and development spending was $207 million in 2025, or 9% of revenue, underscoring its focus on innovation. As of June 30, 2025, non‑affiliate common stock held a market value of about $5.94 billion, and 44,941,206 common shares were outstanding as of February 12, 2026.
The report outlines significant risks, including long utility sales cycles, supply‑chain pressures, competition, cybersecurity threats, and exposure to global economic conditions. It also highlights a workforce of 4,987 employees across the Americas, EMEA, and Asia Pacific and notes total outstanding indebtedness of $1.3 billion alongside a $750 million revolving credit facility.
Itron, Inc. reported mixed fourth quarter and full-year 2025 results, with lower revenue but sharply higher profit, margins and cash flow. Q4 revenue was $572 million and full-year revenue was $2.37 billion, down 7% and 3% from 2024, mainly from portfolio changes and project timing.
GAAP net income attributable to Itron rose to $102 million in Q4 and $301 million for 2025, with diluted EPS of $2.21 and $6.50. Non-GAAP diluted EPS increased to $2.46 in Q4 and $7.13 for the year. Adjusted EBITDA reached $99 million in Q4 and $374 million for 2025, while free cash flow climbed to $112 million for the quarter and $383 million for the year.
Gross margin improved to 40.5% in Q4, driven by a stronger mix. Outcomes revenue grew 23% in the quarter, while Networked Solutions declined 15%. Total backlog ended at $4.5 billion. For 2026, Itron guides revenue of $565–$575 million in Q1 and $2.35–$2.45 billion for the year, with non-GAAP EPS of $1.20–$1.30 in Q1 and $5.75–$6.25 for 2026. The company also closed the $525 million cash-funded acquisition of Locusview in January 2026 and added Urbint, expanding its AI-driven resiliency and software offerings.
Itron, Inc. executive Laurie Ann Pulatie-Hahn, SVP of Human Resources, reported an open-market sale of company common stock. On 02/11/2026, she sold 142 shares of Itron common stock at $105.2648 per share. According to the filing, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, which is a common administrative transaction rather than a discretionary sale. After this transaction, she beneficially owned 21,783 shares of Itron common stock directly.
Laurie A. Hahn filed a notice of proposed sale of 142 shares of common stock under Rule 144, to be sold through Fidelity Brokerage Services LLC on February 11, 2026 on NASDAQ, with an aggregate market value of $14,947.60.
The 142 shares were acquired on February 10, 2026 via restricted stock vesting from the issuer as compensation. The notice also reports prior sales of 76 shares for $7,683.22 on November 11, 2025 and 108 shares for $10,422.66 on November 24, 2025.
Itron, Inc. director stock activity: A member of Itron's board of directors reported receiving a grant of 220 shares of common stock on 01/02/2026 as part of the quarterly compensation that independent directors receive for board service. The shares were reported at a price of $0, reflecting that they were granted, not purchased in the market. Following this grant, the director beneficially owned 15,773 shares directly.
The filing notes that the director, Mr. Leyden, deferred receipt of 82 of these shares under Itron's Executive Deferred Compensation Plan. The amendment also corrects an earlier arithmetic error by adding 9 shares that were inadvertently omitted in a prior report.
Itron, Inc. reported an amended insider filing showing a routine equity grant to a board member. On 01/02/2026, an independent director, Mr. Drury, was granted 555 shares of Itron common stock at a stated price of $0 as part of the quarterly stock compensation that independent members of the board receive for their service. After this grant, he beneficially owned 1,143 common shares in direct form.
The filing explains that Mr. Drury deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the shares are credited but delivery is postponed according to the plan’s terms. The amendment clarifies that 26 shares were previously omitted due to an arithmetic error, and are now included in the reported ownership figure.
Itron, Inc. reported an amended insider filing for a board member. On 01/02/2026, an independent director received a grant of 555 shares of Itron common stock as part of the quarterly equity compensation that independent members of the board receive for their service. The shares were granted at a stated price of $0, reflecting that this was board compensation rather than an open‑market purchase.
Following this grant and the correction, the director beneficially owns 9,564 shares of Itron common stock. The amendment explains that 26 shares were previously omitted due to an arithmetic error and are now included in the reported holdings.
Itron, Inc. reported that one of its directors received a grant of 555 shares of common stock on 01/02/2026 as part of the quarterly equity compensation paid to independent board members. The shares were issued at a stated price of $0, reflecting a compensatory award rather than an open-market purchase.
The amended filing corrects a prior arithmetic error by adding 26 shares that were previously omitted. Following this correction and the reported grant, the director now beneficially owns 5,623 shares of Itron common stock in direct ownership.
Itron, Inc. reported an amended insider transaction for a board member. On 01/02/2026, the director received 555 shares of common stock at a stated price of $0, reflecting the quarterly stock grant that independent directors receive as part of their annual board compensation. Following this grant, the director beneficially owned 11,318 shares directly.
The amendment clarifies that the reported holdings now include an additional 26 shares that were previously omitted due to an arithmetic error, ensuring the ownership total is accurate.